No Data
No Data
Genetic Signatures' Sales Drop in Fiscal Q3
Genetic Signatures (ASX:GSS) logged sales of AU$1.7 million for the third quarter of fiscal 2024, down from AU$2 million in the year-ago period, according to an April 26 filing with the Australian bou
Shareholders in Genetic Signatures (ASX:GSS) Are in the Red If They Invested Three Years Ago
Genetic Signatures Price Target Cut 6.3% to A$0.75/Share by Bell Potter
Genetic Signatures Price Target Cut 6.3% to A$0.75/Share by Bell Potter
Genetic Signatures Completes Rights Issue
Genetic Signatures (ASX:GSS) completed an underwritten rights issue on Jan. 18, the molecular diagnostics company said Wednesday. The rights issue closed with valid applications for entitlements of AU
Genetic Signatures Target Price Cut 3.6% to A$0.80/Share by Bell Potter>GSS.AU
Genetic Signatures Target Price Cut 3.6% to A$0.80/Share by Bell Potter>GSS.AU
These Small Cap ASX Shares Can Rise 30% to 80%: Bell Potter
There could be some very big returns on offer at the small side of the market according to analysts at Bell Potter.
No Data